Using Win Odds to Improve Commit‐to‐Phase‐3 Decision‐Making in Oncology

Documenti analoghi

• Longitudinal Extension of the Win Odds for Ordinal Repeated Measurements
  di: Yongxi Long, et al.
  Pubblicazione: (2026)
• Extending the Median Odds Ratio ( MOR ), the Interval Odds Ratio ( IOR ), and the Proportion of Opposed Odds Ratios ( POOR ) for Use With 3‐Level Multilevel Logistic Regression Models
  di: Peter C. Austin, et al.
  Pubblicazione: (2026)
• Cumulative Logit Ordinal Regression With Proportional Odds Under Nonignorable Missing Responses—Application to Phase III Trial
  di: Arnab Kumar Maity, et al.
  Pubblicazione: (2025)
• The Win Ratio Approach in Bayesian Monitoring for Two‐Arm Phase II Clinical Trial Designs With Multiple Time‐To‐Event Endpoints
  di: Xinran Huang, et al.
  Pubblicazione: (2024)
• Defining Utility as a Measure of Preference Under Uncertainty in Phase I– II Oncology Dose Finding Trials
  di: Andrew Hall, et al.
  Pubblicazione: (2026)